MiRNA-126 has an inhibitory effect on NSCLC cell invasion by silencing oncogenes: VEGFA (Vascular Endothelial Growth Factor A), AKT1 (AKT Serine/Threonine Kinase 1) and KRAS (Kirsten Rat Sarcoma Virus Proto-Oncogene, GTPase) (22). Here, KRAS is linked to non-small cell lung carcinoma.